Based on a field alert report for packaging and labeling compliance for unit III, the FDA has asked the company for submitting a detailed action plan on rectifying the situation.
In its warning letter, the FDA has also asked Aurobindo Pharma for submitting the action plan within 15 working days.
The company has requested the FDA for the meeting date and is in the process of submitting a detailed action plan.